Cargando…
433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
Autores principales: | Hernandez, R., Cogen, J., Blanchard, A., Waters, V., Downey, D., Hoffman, L., Hewko, S., Quon, B., Yau, Y., Stephenson, A., Julien, J., Dupont, L., Groves, H., van Koningsbruggen-Rietschel, S., Simmonds, N., Somayaji, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518485/ http://dx.doi.org/10.1016/S1569-1993(21)01857-9 |
Ejemplares similares
-
490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021) -
SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020) -
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2021) -
P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020
por: Van Koningsbruggen-Rietschel, S., et al.
Publicado: (2021) -
Getting Near to “Closing the Gap” in the Pediatric Age
Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021)